Shenzhen Beike Bio-Technology Co., Ltd.: Clinical Trials

8 trials sponsored by Shenzhen Beike Bio-Technology Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 2 completed, 1 recruiting. 8 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Unknown 5, Completed 2, Recruiting 1
Phase 28Unknown 5, Completed 2, Recruiting 1

Follow Shenzhen Beike Bio-Technology Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
hUC-MSCs treatment (low dose), hUC-MSCs treatment (medium dose), hUC-MSCs treatment (high dose) - Systemic Lupus Erythematosus (SLE)
Phase 1 / Phase 2RecruitingShenzhen Beike Bio-Technology Co., Ltd.582025-06-282025-06-27
Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
human umbilical cord mesenchymal stem cells, hUCMSCs and hCBMNCs, human cord blood mononuclear cells - Premature Ovarian Failure,
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.402012-03-012012-12-05
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
human umbilical cord mesenchymal stem cells - Duchenne Muscular Dystrophy
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.152011-10-012012-11-30
Allogenic Stem Cell Therapy in Patients With Acute Burn
human umbilical cord mesenchymal stem cells, human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells, Conventional therapy - Burns
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.202011-07-012012-11-28
Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis
conventional therapy plus low dose hUC-MSCs treatment, conventional therapy plus medium dose hUC-MSCs treatment, conventional therapy plus high dose hUC-MSCs treatment - Liver Cirrhosis
Phase 1 / Phase 2CompletedShenzhen Beike Bio-Technology Co., Ltd.202010-10-012011-10-14
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia
human umbilical cord mesenchymal stem cells - Hereditary Ataxia
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.202010-01-012012-11-28
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica
human umbilical cord mesenchymal stem cells - Progressive Multiple Sclerosis, Neuromyelitis Optica.
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.202010-01-012012-11-28
Safety and Efficacy of Stem Cell Therapy in Patients With Autism
human cord blood mononuclear cells, human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells - Autism
Phase 1 / Phase 2CompletedShenzhen Beike Bio-Technology Co., Ltd.372009-03-012011-10-14

Conditions studied

Autistic Disorder (1)  ·  Burns (1)  ·  Liver Cirrhosis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Muscular Dystrophy, Duchenne (1)  ·  Neuromyelitis Optica (1)  ·  Primary Ovarian Insufficiency (1)  ·  Spinocerebellar Degenerations (1)

Interventions

Hormone Replacement Therapy (1)

Countries

China (8)

Top investigators

Chengwei Chen (1)  ·  Liqing Yao (1)  ·  Yongtao Lv (1)

Results publications

PMID 23151076, PMID 23978163